Cancer Profiling Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Cancer Profiling Market is expected to grow from USD 8.46 billion in 2020 to USD 18.53 billion by 2027, at a CAGR of 10% during the forecast period 2021-2027.

Cancer profiling is done to obtain genetic information about tumor cells that provides useful insights and information about the disease. Cancer profiling is done to help select the appropriate treatment for cancer. Cancer profiling is an alternative to all conventional approaches to cancer treatment. It uses a personalized approach with a focus on treatment that specifically targets the individual patient’s tumor. Laboratory tests are performed to identify specific genes or genetic mutations (changes), proteins, or other biomarkers in tumor tissue samples to provide better, personalized treatment for cancer patients.

Market Segments

By Technology

• Immunoassays
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Mass Spectrometry
• In-Situ Hybridization
• Microarrays
• Others 

By Cancer Type

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer
• Other Cancer 

By Biomarker Type

• Genomic Biomarker
• Protein Biomarker 

Key Players

Key players operating in the global cancer profiling market include Illumina, Inc., NeoGenomics Laboratories, Inc., Genomic Health Inc., Helomics Corporation, NanoString Technologies, Inc., Ribomed Biotechnologies, Inc, Roche Diagnostics, Tempus Labs, Histogene X, and GenScript Biotech Corporation, among others.

Scope of the Report

The research study analyzes the global Cancer Profiling industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Cancer Profiling Market Report

1. What was the Cancer Profiling Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Cancer Profiling Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Cancer Profiling Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.